The U.S. Hemophilia Treatment Market is driven by rising prevalence of bleeding disorders
The U.S. hemophilia treatment market involves treatments aimed at managing symptoms and preventing complications of hemophilia - a rare genetic bleeding disorder that impairs the body's ability to control bleeding or clotting. There are two main types of hemophilia: hemophilia A, which affects the clotting factor VIII, and hemophilia B, which affects factor IX. Conventional treatment involves...
0 Kommentare
0 Anteile